Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-31 Purchase | 2022-06-08 9:28 pm | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO | 7,656 | $1.47 | $11,254 | 7,656 (Direct) | View |
| 2022-05-31 Purchase | 2022-06-08 9:27 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. CFO | 7,656 | $1.47 | $11,254 | 7,656 (Direct) | View |
| 2022-05-31 Purchase | 2022-06-08 9:27 pm | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel CEO | 7,656 | $1.47 | $11,254 | 7,656 (Direct) | View |
| 2021-02-09 Purchase | 2021-02-09 3:10 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) | View |
| 2021-02-09 Purchase | 2021-02-09 3:09 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner | 475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) | View |
| 2021-02-09 Purchase | 2021-02-09 3:08 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 475,000 | $17 | $8,075,000 | 357,353 (Indirect) | View |
| 2021-02-09 Purchase | 2021-02-09 2:55 pm | Terns Pharmaceuticals Inc. | TERN | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. 10% Owner | 665,000 | $17 | $11,305,000 | 2,382,033 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-26 Option Award | 2022-07-28 8:08 pm | N/A 2032-07-25 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 8:07 pm | N/A 2032-06-30 | Terns Pharmaceuticals Inc. | TERN | Russell Kerry Strong Chief Medical Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 9:02 pm | N/A 2032-01-26 | Terns Pharmaceuticals Inc. | TERN | Quirk Erin President CMO and Head of R & D | 92,500 | $0 | 92,500 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 9:02 pm | N/A 2032-01-26 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. CFO | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 9:01 pm | N/A 2032-01-26 | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 9:00 pm | N/A 2032-01-26 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel CEO | 280,000 | $0 | 280,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-10-12 9:20 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:17 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:17 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. CFO | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:17 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:14 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Quirk Erin President and CMO | 142,500 | $0 | 142,500 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:13 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel CEO | 315,000 | $0 | 315,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:11 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:09 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:04 pm | N/A 2031-02-23 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:03 pm | N/A 2031-02-23 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-09 Conversion | 2021-02-09 5:00 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | LAV Biosciences Fund V L.P. Hopewell Resources Holdings Ltd Oriental Spring Venture Ltd LAV Aqua Ltd 10% Owner | 6,068,264 | $0 | 1,405,583 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 3:10 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 6,632,408 | $0 | 2,274,723 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 3:09 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner | 6,632,408 | $0 | 2,274,723 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 3:08 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 3,426,240 | $0 | 357,353 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 2:55 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. 10% Owner | 1,717,033 | $0 | 2,382,033 (Indirect) | View |
| 2020-02-04 Ownership | 2021-02-04 7:55 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. 10% Owner | 0 | $0 | 1,717,033 (Indirect) | View |
| 2021-02-04 Ownership | 2021-02-04 5:16 pm | N/A 2030-08-12 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel CEO | 0 | $0 | 949,197 (Direct) | View |
| 2021-02-04 Ownership | 2021-02-04 5:15 pm | N/A 2029-01-10 | Terns Pharmaceuticals Inc. | TERN | Quirk Erin See Remarks | 0 | $0 | 379,678 (Direct) | View |
| 2021-02-04 Ownership | 2021-02-04 5:14 pm | N/A 2030-09-09 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. CFO | 0 | $0 | 227,807 (Direct) | View |
| 2021-02-04 Ownership | 2021-02-04 5:13 pm | N/A 2030-12-29 | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan See Remarks | 0 | $0 | 265,775 (Direct) | View |
| 2021-02-04 Ownership | 2021-02-04 5:12 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Zhong Weidong Chief Scientific Officer | 0 | $0 | 513,520 (Direct) | View |
| 2021-02-04 Ownership | 2021-02-04 5:11 pm | N/A 2030-12-29 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 0 | $0 | 28,475 (Direct) | View |